Last reviewed · How we verify
NCT03571919: Lidocare
Lidocaine Infusions for Rib Fractures
Phase 4 trial testing Lidocaine infusion in Rib Fracture Multiple. Withdrawn.
1 June 2019
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Start date | 15 June 2018 |
| Primary completion | 1 June 2019 |
| Estimated completion | 1 July 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lidocaine infusion — full drug profile →
- Saline infusion — full drug profile →
Conditions studied
- Rib Fracture Multiple — all drugs for Rib Fracture Multiple →
- Trauma Chest — all drugs for Trauma Chest →
- Pain, Acute — all drugs for Pain, Acute →
Sponsor
Stanford University
Who can join
18 and older, any sex, with Rib Fracture Multiple or Trauma Chest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with traumatic rib fractures not receiving regional anesthesia through a epidural or nerve block catheter will be recruited for the study. Once enrolled, they will be randomized to receive either intravenous lidocaine or intravenous saline for control of pain related to their rib fractures. In addition, they will receive other pain medications, such as acetaminophen, gabapentin, and opioid pain medications. Our primary outcome is a decrease in their opioid medication requirements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03571919
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lidocaine infusion
Trials testing the same drug.
- NCT04706767 — Effect of Co-administration Lidocaine and Dexmedetomidine on Quality of Recovery · NA · completed
- NCT04140396 — Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia · Phase 4 · terminated
- NCT03809923 — Dexmedetomidine Combined With Lidocaine Infusion Affect PONV · NA · completed
Other recruiting trials for Rib Fracture Multiple
Currently open trials in the same condition.
- NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting
- NCT05748366 — Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures · NA · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03571919 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 28 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571919.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing